Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRASTUZUMAB-QYYP vs TRAVOPROST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRASTUZUMAB-QYYP vs TRAVOPROST: Safety Overview

Metric TRASTUZUMAB-QYYP TRAVOPROST
Total FAERS Reports 308 6,455
Deaths Reported 30 145
Death Rate 9.7% 2.2%
Hospitalizations 60 164
Average Patient Age 57.0 yrs 71.6 yrs
% Female Patients 92.3% 63.0%
FDA Approval Date N/A Dec 13, 2023
Manufacturer N/A Sagent Pharmaceuticals
Route N/A OPHTHALMIC
Marketing Status Prescription Discontinued